Afghanistan vs Oman: New cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Oman
100.0%
in 2024
Afghanistan rank
1st
Oman rank
1st
New cases tested for RR-/MDR-TB over time
- Afghanistan
- Oman
How they compare
Afghanistan currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2010 it was Oman ahead.
Afghanistan ranks 1st and Oman ranks 1st of 192 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10.9% | 94.9% | 84.0% | Oman |
| 2020s | 68.8% | 91.2% | 22.4% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Afghanistan or Oman?
- Afghanistan, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Afghanistan and Oman?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Oman?
- 13 years are reported by both, from 2010 to 2024.
- How do Afghanistan and Oman rank globally for new cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Oman ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.